181 related articles for article (PubMed ID: 38632300)
1. An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates liquid-solid phase transition.
Shiramasa Y; Yamamoto R; Kashiwagi N; Sasaki F; Imai S; Ike M; Kitazawa S; Kameda T; Kitahara R
Sci Rep; 2024 Apr; 14(1):8914. PubMed ID: 38632300
[TBL] [Abstract][Full Text] [Related]
2. Mechanism underlying liquid-to-solid phase transition in fused in sarcoma liquid droplets.
Li S; Yoshizawa T; Shiramasa Y; Kanamaru M; Ide F; Kitamura K; Kashiwagi N; Sasahara N; Kitazawa S; Kitahara R
Phys Chem Chem Phys; 2022 Aug; 24(32):19346-19353. PubMed ID: 35943083
[TBL] [Abstract][Full Text] [Related]
3. Pressure-Jump Kinetics of Liquid-Liquid Phase Separation: Comparison of Two Different Condensed Phases of the RNA-Binding Protein, Fused in Sarcoma.
Kitahara R; Yamazaki R; Ide F; Li S; Shiramasa Y; Sasahara N; Yoshizawa T
J Am Chem Soc; 2021 Dec; 143(47):19697-19702. PubMed ID: 34787417
[TBL] [Abstract][Full Text] [Related]
4. Pressure and Temperature Phase Diagram for Liquid-Liquid Phase Separation of the RNA-Binding Protein Fused in Sarcoma.
Li S; Yoshizawa T; Yamazaki R; Fujiwara A; Kameda T; Kitahara R
J Phys Chem B; 2021 Jul; 125(25):6821-6829. PubMed ID: 34156864
[TBL] [Abstract][Full Text] [Related]
5. ALS-linked FUS mutations dysregulate G-quadruplex-dependent liquid-liquid phase separation and liquid-to-solid transition.
Ishiguro A; Lu J; Ozawa D; Nagai Y; Ishihama A
J Biol Chem; 2021 Nov; 297(5):101284. PubMed ID: 34624313
[TBL] [Abstract][Full Text] [Related]
6. ATP enhances at low concentrations but dissolves at high concentrations liquid-liquid phase separation (LLPS) of ALS/FTD-causing FUS.
Kang J; Lim L; Song J
Biochem Biophys Res Commun; 2018 Oct; 504(2):545-551. PubMed ID: 30205960
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of karyopherin-β2 binding and nuclear import of ALS variants FUS(P525L) and FUS(R495X).
Gonzalez A; Mannen T; Çağatay T; Fujiwara A; Matsumura H; Niesman AB; Brautigam CA; Chook YM; Yoshizawa T
Sci Rep; 2021 Feb; 11(1):3754. PubMed ID: 33580145
[TBL] [Abstract][Full Text] [Related]
8. Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
Pakravan D; Orlando G; Bercier V; Van Den Bosch L
J Mol Cell Biol; 2021 Apr; 13(1):15-28. PubMed ID: 32976566
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity.
Nakaya T; Maragkakis M
Sci Rep; 2018 Oct; 8(1):15575. PubMed ID: 30349096
[TBL] [Abstract][Full Text] [Related]
10. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
11. The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation.
Reber S; Jutzi D; Lindsay H; Devoy A; Mechtersheimer J; Levone BR; Domanski M; Bentmann E; Dormann D; Mühlemann O; Barabino SML; Ruepp MD
Nucleic Acids Res; 2021 Jul; 49(13):7713-7731. PubMed ID: 34233002
[TBL] [Abstract][Full Text] [Related]
12. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation.
Patel A; Lee HO; Jawerth L; Maharana S; Jahnel M; Hein MY; Stoynov S; Mahamid J; Saha S; Franzmann TM; Pozniakovski A; Poser I; Maghelli N; Royer LA; Weigert M; Myers EW; Grill S; Drechsel D; Hyman AA; Alberti S
Cell; 2015 Aug; 162(5):1066-77. PubMed ID: 26317470
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic granule formation by FUS-R495X is attributable to arginine methylation in all Gly-rich, RGG1 and RGG2 domains.
Kawahara D; Suzuki T; Nakaya T
Genes Cells; 2021 Mar; 26(3):190-197. PubMed ID: 33411976
[TBL] [Abstract][Full Text] [Related]
14. ALS-causing hPFN1 mutants differentially disrupt LLPS of FUS prion-like domain.
Kang J; Lim L; Song J
Biochem Biophys Res Commun; 2023 Jul; 664():35-42. PubMed ID: 37130459
[TBL] [Abstract][Full Text] [Related]
15. A dynamic regulatory switch for phase separation of FUS protein: Zinc ions and zinc finger domain.
Chen Y; Pei X; Chen L; Chen L
Biochem Biophys Res Commun; 2024 May; 710():149862. PubMed ID: 38593618
[TBL] [Abstract][Full Text] [Related]
16. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
[TBL] [Abstract][Full Text] [Related]
17. A unified mechanism for LLPS of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic acids.
Kang J; Lim L; Lu Y; Song J
PLoS Biol; 2019 Jun; 17(6):e3000327. PubMed ID: 31188823
[TBL] [Abstract][Full Text] [Related]
18. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
[TBL] [Abstract][Full Text] [Related]
19. How can we interpret the relationship between liquid-liquid phase separation and amyotrophic lateral sclerosis?
Kanekura K; Kuroda M
Lab Invest; 2022 Sep; 102(9):912-918. PubMed ID: 35459796
[TBL] [Abstract][Full Text] [Related]
20. Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases.
Chen C; Ding X; Akram N; Xue S; Luo SZ
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
